Tirzepatide is a dual GIP and GLP-1 receptor agonist designed for advanced metabolic research. This peptide enhances insulin secretion, improves glucose regulation, and supports weight management by reducing appetite and promoting satiety. With proven efficacy in glycemic control and significant weight loss in clinical studies, Tirzepatide is a powerful tool for exploring metabolic pathways and energy homeostasis.